A study of Erandmuladi netra pindi treatment with haridrakhand (by mouth) in simple allergic conjunctivitis disease.
Not Applicable
- Registration Number
- CTRI/2022/11/047506
- Lead Sponsor
- PDEAs college of ayurved and research centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients from age group of 18 to 50 years irrespective of Gender, Religion, occupation.
2.Patients having atleast 3 signs and symptoms of simple Allergic conjunctivitis as below :
1.Itching
2.Watery discharge
3.Pricking sensation
4.Edema of eyelids
5.Hyperemia
6.Chemosis
Exclusion Criteria
1.Known case of congenital anomalies of eye, ocular pathology, conjunctivitis with corneal involvement, infective conjunctivitis.
2.Patient with the history of recent ophthalmic surgeries.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method to identify the difference of treatment for management of simple allergic conjunctivitis.to compare the effectivenss of treatment over period of time.to compare the efficacy of haridrakhand with and without erandmuladi pindi in simple allergic conjunctivitis.Timepoint: 15 days treatment with two followups on 7th and 15th day. <br/ ><br>symptoms of simple allergic conjunctivitis seen reduced in 1 week
- Secondary Outcome Measures
Name Time Method 1.To assess the efficacy of erandmuladi netra pindi 7 days with haridrakhand orally for 15 days with obsevation of reduced clinical features. <br/ ><br>2.To assess the effect of erandmuladi netra pindi 7 days without haridrakhand orally with observation of reduced clinical features. <br/ ><br>to observe the adverse effect of drug if any.Timepoint: 15 days treatment with two followups on 7th and 15th day.